Bedel Financial Consulting’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-1,432
Closed -$37K – 387
2022
Q1
$37K Hold
1,432
– – 0.01% 442
2021
Q4
$41K Hold
1,432
– – 0.01% 430
2021
Q3
$46K Hold
1,432
– – 0.02% 388
2021
Q2
$50K Hold
1,432
– – 0.02% 376
2021
Q1
$42K Hold
1,432
– – 0.02% 386
2020
Q4
$44K Hold
1,432
– – 0.02% 335
2020
Q3
$40K Buy
1,432
+880
+159% +$22.3K 0.02% 334
2020
Q2
$12K Buy
552
+100
+22% +$2.21K 0.01% 461
2020
Q1
$10K Hold
452
– – 0.01% 470
2019
Q4
$13K Hold
452
– – 0.01% 458
2019
Q3
$12K Hold
452
– – 0.01% 452
2019
Q2
$15K Hold
452
– – 0.01% 425
2019
Q1
$14K Buy
452
+22
+5% +$677 0.01% 436
2018
Q4
$14K Buy
+430
New +$14.1K 0.01% 409

Other funds holding ELAN

Bedel Financial Consulting's ELAN Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Elanco Animal Health (ELAN) in Q2 2022, closing a stake of 1,432 shares — an estimated $37K sold.

Bedel Financial Consulting first reported a position in ELAN in Q4 2018 and held it in 14 quarters. The position peaked at $50K in Q2 2021. 438 funds tracked by Wall St. Rank hold ELAN as of Q2 2022.

  • Bedel Financial Consulting reported no remaining Elanco Animal Health position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 1,432 Elanco Animal Health shares in Q2 2022, an estimated $37K.
  • Bedel Financial Consulting first reported a position in Elanco Animal Health in Q4 2018 and held it in 14 quarters.
  • Bedel Financial Consulting's Elanco Animal Health position peaked at $50K in Q2 2021.
  • 438 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.